George Nick Papaliodis, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Uveitis | 23 | 2024 | 398 | 5.220 |
Why?
|
Cataract | 4 | 2023 | 837 | 1.370 |
Why?
|
Uveitis, Anterior | 5 | 2023 | 103 | 1.270 |
Why?
|
Uveitis, Posterior | 4 | 2022 | 45 | 0.910 |
Why?
|
Scleritis | 6 | 2022 | 96 | 0.900 |
Why?
|
Pemphigoid, Benign Mucous Membrane | 5 | 2023 | 113 | 0.880 |
Why?
|
Behcet Syndrome | 4 | 2017 | 86 | 0.840 |
Why?
|
Conjunctival Diseases | 2 | 2016 | 109 | 0.790 |
Why?
|
Eye Diseases | 5 | 2017 | 660 | 0.700 |
Why?
|
Cataract Extraction | 2 | 2017 | 464 | 0.680 |
Why?
|
Corneal Diseases | 5 | 2022 | 535 | 0.680 |
Why?
|
Retinal Vasculitis | 3 | 2017 | 46 | 0.670 |
Why?
|
Stevens-Johnson Syndrome | 4 | 2016 | 232 | 0.660 |
Why?
|
Visual Acuity | 11 | 2020 | 2714 | 0.650 |
Why?
|
Systemic Vasculitis | 1 | 2017 | 37 | 0.570 |
Why?
|
Specialization | 1 | 2021 | 779 | 0.520 |
Why?
|
Cogan Syndrome | 1 | 2015 | 10 | 0.490 |
Why?
|
Lenses, Intraocular | 2 | 2010 | 141 | 0.480 |
Why?
|
Macular Edema | 3 | 2020 | 387 | 0.460 |
Why?
|
Ophthalmology | 1 | 2021 | 560 | 0.460 |
Why?
|
Spondylarthropathies | 1 | 2013 | 14 | 0.450 |
Why?
|
Eyelid Diseases | 1 | 2016 | 155 | 0.440 |
Why?
|
Immunomodulation | 2 | 2016 | 549 | 0.410 |
Why?
|
Glucocorticoids | 4 | 2020 | 2167 | 0.400 |
Why?
|
Vasculitis | 2 | 2015 | 525 | 0.370 |
Why?
|
Moyamoya Disease | 1 | 2015 | 274 | 0.370 |
Why?
|
Anti-Inflammatory Agents | 5 | 2018 | 1805 | 0.360 |
Why?
|
Eye | 1 | 2015 | 712 | 0.360 |
Why?
|
Burns, Chemical | 2 | 2023 | 123 | 0.340 |
Why?
|
Pemphigus | 1 | 2010 | 107 | 0.310 |
Why?
|
Paraneoplastic Syndromes | 1 | 2010 | 154 | 0.300 |
Why?
|
Retina | 2 | 2018 | 2662 | 0.290 |
Why?
|
Anterior Chamber | 1 | 2008 | 194 | 0.290 |
Why?
|
Glaucoma | 4 | 2023 | 1194 | 0.270 |
Why?
|
Vitreous Body | 4 | 2017 | 401 | 0.260 |
Why?
|
Immunosuppressive Agents | 6 | 2024 | 4206 | 0.260 |
Why?
|
Antibodies, Monoclonal | 6 | 2013 | 9263 | 0.260 |
Why?
|
Ischemia | 1 | 2015 | 1900 | 0.260 |
Why?
|
Syphilis | 3 | 2016 | 243 | 0.250 |
Why?
|
Immunoglobulin G | 5 | 2023 | 4568 | 0.250 |
Why?
|
Tumor Necrosis Factor-alpha | 4 | 2023 | 4352 | 0.250 |
Why?
|
Eye Infections | 2 | 2019 | 63 | 0.240 |
Why?
|
Chorioretinitis | 2 | 2022 | 43 | 0.240 |
Why?
|
Polymyalgia Rheumatica | 2 | 2015 | 52 | 0.230 |
Why?
|
Prostheses and Implants | 4 | 2022 | 1276 | 0.220 |
Why?
|
Telemedicine | 1 | 2021 | 3109 | 0.220 |
Why?
|
Pregnancy Complications | 1 | 2016 | 2973 | 0.200 |
Why?
|
Perioperative Care | 1 | 2010 | 1043 | 0.190 |
Why?
|
Conjunctivitis | 1 | 2003 | 153 | 0.190 |
Why?
|
Biological Products | 1 | 2011 | 948 | 0.190 |
Why?
|
Prosthesis Implantation | 4 | 2022 | 594 | 0.190 |
Why?
|
Retinal Diseases | 2 | 2018 | 710 | 0.190 |
Why?
|
Lymphoma, B-Cell | 1 | 2008 | 945 | 0.190 |
Why?
|
Phacoemulsification | 1 | 2002 | 151 | 0.180 |
Why?
|
Lens Implantation, Intraocular | 1 | 2002 | 192 | 0.180 |
Why?
|
Tenon Capsule | 1 | 2020 | 6 | 0.170 |
Why?
|
Cornea | 3 | 2023 | 1316 | 0.170 |
Why?
|
Injections, Intraocular | 1 | 2020 | 36 | 0.170 |
Why?
|
Giant Cell Arteritis | 2 | 2017 | 307 | 0.170 |
Why?
|
Optic Nerve | 1 | 2023 | 571 | 0.170 |
Why?
|
Toxoplasmosis, Ocular | 2 | 2019 | 29 | 0.170 |
Why?
|
Coated Materials, Biocompatible | 2 | 2017 | 311 | 0.170 |
Why?
|
Postoperative Complications | 2 | 2017 | 15832 | 0.160 |
Why?
|
Keratoconjunctivitis Sicca | 1 | 2019 | 26 | 0.160 |
Why?
|
Uveomeningoencephalitic Syndrome | 1 | 2019 | 22 | 0.160 |
Why?
|
Retrospective Studies | 18 | 2024 | 81762 | 0.160 |
Why?
|
Triamcinolone Acetonide | 1 | 2020 | 105 | 0.160 |
Why?
|
Drug Delivery Systems | 1 | 2010 | 2232 | 0.160 |
Why?
|
Autoimmune Diseases | 5 | 2016 | 2257 | 0.160 |
Why?
|
Humans | 57 | 2024 | 768166 | 0.150 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2010 | 1642 | 0.150 |
Why?
|
Toxoplasma | 2 | 2019 | 159 | 0.150 |
Why?
|
Neoplasms | 3 | 2024 | 22371 | 0.150 |
Why?
|
Annexins | 1 | 2018 | 40 | 0.150 |
Why?
|
Intraocular Pressure | 3 | 2020 | 1304 | 0.150 |
Why?
|
Vitamin D Deficiency | 2 | 2018 | 1388 | 0.150 |
Why?
|
Fluocinolone Acetonide | 1 | 2017 | 38 | 0.140 |
Why?
|
Tomography, Optical Coherence | 3 | 2017 | 2957 | 0.140 |
Why?
|
Ciliary Body | 1 | 2018 | 168 | 0.140 |
Why?
|
Incidence | 3 | 2024 | 21538 | 0.140 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 2 | 2011 | 696 | 0.140 |
Why?
|
Sclera | 1 | 2018 | 189 | 0.130 |
Why?
|
HLA-B Antigens | 2 | 2008 | 330 | 0.130 |
Why?
|
Glaucoma Drainage Implants | 1 | 2017 | 107 | 0.130 |
Why?
|
Antimetabolites | 1 | 2016 | 128 | 0.130 |
Why?
|
rab GTP-Binding Proteins | 1 | 2018 | 247 | 0.130 |
Why?
|
Vitamin D | 3 | 2022 | 3311 | 0.130 |
Why?
|
Laser Coagulation | 1 | 2018 | 334 | 0.130 |
Why?
|
Fluorescein Angiography | 3 | 2022 | 1086 | 0.130 |
Why?
|
Axons | 1 | 2023 | 1677 | 0.120 |
Why?
|
Optic Nerve Diseases | 1 | 2019 | 342 | 0.120 |
Why?
|
Diagnosis, Differential | 7 | 2016 | 13014 | 0.120 |
Why?
|
Biological Therapy | 1 | 2016 | 140 | 0.120 |
Why?
|
Artificial Organs | 1 | 2016 | 149 | 0.120 |
Why?
|
Antibodies, Protozoan | 1 | 2015 | 251 | 0.110 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2010 | 4058 | 0.110 |
Why?
|
Panuveitis | 1 | 2014 | 33 | 0.110 |
Why?
|
Fundus Oculi | 1 | 2015 | 560 | 0.110 |
Why?
|
Optic Disk | 1 | 2017 | 421 | 0.110 |
Why?
|
Adult | 23 | 2024 | 223646 | 0.100 |
Why?
|
Acute Disease | 1 | 2023 | 7243 | 0.100 |
Why?
|
Middle Aged | 25 | 2024 | 223492 | 0.100 |
Why?
|
Sarcoidosis | 1 | 2018 | 535 | 0.100 |
Why?
|
Cyclophosphamide | 3 | 2008 | 2227 | 0.100 |
Why?
|
Female | 28 | 2024 | 397192 | 0.100 |
Why?
|
Susac Syndrome | 1 | 2011 | 22 | 0.100 |
Why?
|
Exanthema | 1 | 2016 | 503 | 0.090 |
Why?
|
Graft vs Host Disease | 1 | 2023 | 3049 | 0.090 |
Why?
|
Prednisolone | 2 | 2010 | 326 | 0.090 |
Why?
|
Male | 29 | 2024 | 364719 | 0.090 |
Why?
|
Databases, Factual | 2 | 2024 | 8080 | 0.090 |
Why?
|
Aged | 17 | 2024 | 171504 | 0.090 |
Why?
|
Risk Factors | 5 | 2024 | 74944 | 0.080 |
Why?
|
Postpartum Period | 1 | 2016 | 1198 | 0.080 |
Why?
|
Hypesthesia | 1 | 2010 | 106 | 0.080 |
Why?
|
Blindness | 2 | 2010 | 587 | 0.080 |
Why?
|
Vaccinium myrtillus | 1 | 2009 | 1 | 0.080 |
Why?
|
Gene Rearrangement, T-Lymphocyte | 1 | 2009 | 111 | 0.080 |
Why?
|
International Classification of Diseases | 1 | 2015 | 937 | 0.080 |
Why?
|
Receptors, Tumor Necrosis Factor | 1 | 2011 | 587 | 0.080 |
Why?
|
Anthocyanins | 1 | 2009 | 80 | 0.080 |
Why?
|
Temporal Arteries | 1 | 2010 | 155 | 0.080 |
Why?
|
Suppuration | 1 | 2008 | 61 | 0.080 |
Why?
|
Lens Diseases | 1 | 2008 | 13 | 0.080 |
Why?
|
Complement C3 | 1 | 2010 | 434 | 0.070 |
Why?
|
Prosthesis Design | 2 | 2017 | 2125 | 0.070 |
Why?
|
Iris Diseases | 1 | 2008 | 36 | 0.070 |
Why?
|
Aqueous Humor | 1 | 2008 | 152 | 0.070 |
Why?
|
Integrin beta4 | 1 | 2007 | 29 | 0.070 |
Why?
|
Eye Infections, Bacterial | 1 | 2010 | 239 | 0.070 |
Why?
|
HLA-A Antigens | 1 | 2008 | 223 | 0.070 |
Why?
|
Injections, Spinal | 1 | 2008 | 317 | 0.070 |
Why?
|
Pain, Postoperative | 1 | 2018 | 1765 | 0.070 |
Why?
|
Anterior Eye Segment | 1 | 2008 | 144 | 0.070 |
Why?
|
Retinal Neoplasms | 1 | 2009 | 151 | 0.070 |
Why?
|
Follow-Up Studies | 4 | 2024 | 39348 | 0.070 |
Why?
|
Phytotherapy | 1 | 2009 | 298 | 0.070 |
Why?
|
Tongue | 1 | 2010 | 406 | 0.070 |
Why?
|
Lymphoma, T-Cell | 1 | 2009 | 308 | 0.070 |
Why?
|
Antirheumatic Agents | 1 | 2016 | 1381 | 0.070 |
Why?
|
Plasmapheresis | 1 | 2006 | 206 | 0.060 |
Why?
|
Vincristine | 1 | 2008 | 1040 | 0.060 |
Why?
|
Chronic Disease | 2 | 2016 | 9384 | 0.060 |
Why?
|
Headache | 2 | 2011 | 1263 | 0.060 |
Why?
|
Lung Neoplasms | 1 | 2010 | 13586 | 0.060 |
Why?
|
Pars Planitis | 1 | 2004 | 7 | 0.060 |
Why?
|
Major Histocompatibility Complex | 1 | 2008 | 877 | 0.060 |
Why?
|
Leg | 1 | 2010 | 1088 | 0.060 |
Why?
|
Treatment Outcome | 8 | 2020 | 65371 | 0.060 |
Why?
|
Antimetabolites, Antineoplastic | 1 | 2008 | 646 | 0.060 |
Why?
|
Immunophenotyping | 1 | 2009 | 1864 | 0.060 |
Why?
|
Cerebellar Neoplasms | 1 | 2009 | 591 | 0.060 |
Why?
|
Deglutition Disorders | 1 | 2010 | 640 | 0.060 |
Why?
|
Delivery of Health Care | 1 | 2021 | 5367 | 0.050 |
Why?
|
Capsulorhexis | 1 | 2002 | 12 | 0.050 |
Why?
|
Silicone Elastomers | 1 | 2002 | 78 | 0.050 |
Why?
|
Fever | 1 | 2010 | 1614 | 0.050 |
Why?
|
Acrylic Resins | 1 | 2002 | 135 | 0.050 |
Why?
|
T-Lymphocytes | 2 | 2010 | 10266 | 0.050 |
Why?
|
Cohort Studies | 2 | 2023 | 41754 | 0.050 |
Why?
|
Polymethyl Methacrylate | 1 | 2002 | 132 | 0.050 |
Why?
|
Biocompatible Materials | 1 | 2010 | 1702 | 0.050 |
Why?
|
Doxorubicin | 1 | 2008 | 2234 | 0.050 |
Why?
|
Models, Animal | 1 | 2008 | 2120 | 0.050 |
Why?
|
Case-Control Studies | 4 | 2022 | 22291 | 0.050 |
Why?
|
Tomography, X-Ray Computed | 3 | 2015 | 20760 | 0.040 |
Why?
|
Immunoglobulin A | 1 | 2023 | 992 | 0.040 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2009 | 2568 | 0.040 |
Why?
|
Oral Ulcer | 2 | 2010 | 96 | 0.040 |
Why?
|
Flow Cytometry | 1 | 2010 | 5902 | 0.040 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 3 | 2015 | 3814 | 0.040 |
Why?
|
Lymphocyte Activation | 1 | 2010 | 5505 | 0.040 |
Why?
|
Herpesviridae | 1 | 2019 | 104 | 0.040 |
Why?
|
Interleukin-6 | 2 | 2009 | 3228 | 0.040 |
Why?
|
Autoantibodies | 1 | 2007 | 2121 | 0.040 |
Why?
|
Lupus Erythematosus, Systemic | 2 | 2010 | 2171 | 0.040 |
Why?
|
Biopsy | 1 | 2010 | 6793 | 0.040 |
Why?
|
Herpesviridae Infections | 1 | 2019 | 269 | 0.040 |
Why?
|
Carbonic Anhydrase Inhibitors | 1 | 2018 | 92 | 0.040 |
Why?
|
Health Care Costs | 1 | 2010 | 3239 | 0.040 |
Why?
|
Keratoplasty, Penetrating | 1 | 2018 | 143 | 0.040 |
Why?
|
Rabbits | 1 | 2023 | 4772 | 0.040 |
Why?
|
Cerebrospinal Fluid | 2 | 2010 | 540 | 0.030 |
Why?
|
Chromosomes, Human, Pair 6 | 1 | 2018 | 370 | 0.030 |
Why?
|
Hearing Loss | 2 | 2016 | 785 | 0.030 |
Why?
|
Mendelian Randomization Analysis | 1 | 2022 | 1040 | 0.030 |
Why?
|
Syphilis Serodiagnosis | 1 | 2016 | 37 | 0.030 |
Why?
|
Infusions, Intravenous | 2 | 2016 | 2230 | 0.030 |
Why?
|
B-Lymphocytes | 1 | 2010 | 4793 | 0.030 |
Why?
|
HIV Infections | 3 | 2016 | 17569 | 0.030 |
Why?
|
United States | 1 | 2024 | 73039 | 0.030 |
Why?
|
Heparin | 1 | 2002 | 1636 | 0.030 |
Why?
|
Pregnancy | 1 | 2016 | 30256 | 0.030 |
Why?
|
Vitamins | 1 | 2022 | 1638 | 0.030 |
Why?
|
Gait Disorders, Neurologic | 1 | 2016 | 243 | 0.030 |
Why?
|
Child | 3 | 2015 | 80917 | 0.030 |
Why?
|
Arthritis, Psoriatic | 1 | 2016 | 219 | 0.030 |
Why?
|
Immunoassay | 1 | 2017 | 746 | 0.030 |
Why?
|
Neoplasm Staging | 1 | 2008 | 11244 | 0.030 |
Why?
|
Predictive Value of Tests | 2 | 2022 | 15454 | 0.030 |
Why?
|
HIV-1 | 1 | 2010 | 6961 | 0.030 |
Why?
|
DNA, Viral | 1 | 2019 | 2204 | 0.020 |
Why?
|
Sensitivity and Specificity | 2 | 2019 | 14729 | 0.020 |
Why?
|
Aged, 80 and over | 5 | 2017 | 59629 | 0.020 |
Why?
|
Neuroprotective Agents | 1 | 2018 | 958 | 0.020 |
Why?
|
Fluorescein | 1 | 2011 | 176 | 0.020 |
Why?
|
Ophthalmoscopy | 1 | 2011 | 172 | 0.020 |
Why?
|
Retinal Artery | 1 | 2011 | 109 | 0.020 |
Why?
|
Genome-Wide Association Study | 2 | 2022 | 12795 | 0.020 |
Why?
|
Gene Frequency | 1 | 2018 | 3623 | 0.020 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2022 | 16045 | 0.020 |
Why?
|
Cardiolipins | 1 | 2010 | 83 | 0.020 |
Why?
|
Alternaria | 1 | 2010 | 41 | 0.020 |
Why?
|
Epidemiologic Methods | 1 | 2015 | 1328 | 0.020 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2008 | 9419 | 0.020 |
Why?
|
Tongue Diseases | 1 | 2010 | 69 | 0.020 |
Why?
|
Mass Spectrometry | 1 | 2017 | 2202 | 0.020 |
Why?
|
Postoperative Care | 1 | 2016 | 1480 | 0.020 |
Why?
|
Prednisone | 1 | 2014 | 1567 | 0.020 |
Why?
|
Confusion | 1 | 2011 | 278 | 0.020 |
Why?
|
Vision Disorders | 1 | 2016 | 1093 | 0.020 |
Why?
|
False Negative Reactions | 1 | 2010 | 574 | 0.020 |
Why?
|
Phosphatidylcholines | 1 | 2010 | 406 | 0.020 |
Why?
|
Genetic Loci | 1 | 2018 | 2629 | 0.020 |
Why?
|
Young Adult | 4 | 2017 | 60066 | 0.020 |
Why?
|
Mycophenolic Acid | 1 | 2010 | 348 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2002 | 12465 | 0.020 |
Why?
|
HLA-B27 Antigen | 1 | 2008 | 67 | 0.020 |
Why?
|
Adolescent | 5 | 2015 | 89169 | 0.020 |
Why?
|
Prospective Studies | 2 | 2022 | 54926 | 0.020 |
Why?
|
Ophthalmologic Surgical Procedures | 1 | 2010 | 354 | 0.020 |
Why?
|
Apoptosis | 1 | 2023 | 9523 | 0.020 |
Why?
|
Tinnitus | 1 | 2010 | 197 | 0.020 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2008 | 11878 | 0.020 |
Why?
|
Mycoses | 1 | 2010 | 386 | 0.020 |
Why?
|
Tissue Adhesions | 1 | 2008 | 222 | 0.020 |
Why?
|
Alleles | 1 | 2018 | 6894 | 0.020 |
Why?
|
Vocal Cord Paralysis | 1 | 2010 | 275 | 0.020 |
Why?
|
Immunoglobulin Heavy Chains | 1 | 2009 | 648 | 0.020 |
Why?
|
Leukocyte Count | 1 | 2010 | 1609 | 0.020 |
Why?
|
Arthralgia | 1 | 2010 | 459 | 0.020 |
Why?
|
Plant Extracts | 1 | 2009 | 497 | 0.020 |
Why?
|
Antineoplastic Agents | 1 | 2008 | 13676 | 0.020 |
Why?
|
Gene Expression | 1 | 2018 | 7598 | 0.020 |
Why?
|
Pulse Therapy, Drug | 1 | 2004 | 37 | 0.010 |
Why?
|
Fatal Outcome | 1 | 2009 | 1836 | 0.010 |
Why?
|
Brain | 1 | 2011 | 27360 | 0.010 |
Why?
|
CD4 Lymphocyte Count | 1 | 2010 | 2596 | 0.010 |
Why?
|
Memory Disorders | 1 | 2011 | 1200 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2023 | 18349 | 0.010 |
Why?
|
Animals | 2 | 2023 | 169246 | 0.010 |
Why?
|
Interleukin-10 | 1 | 2009 | 1183 | 0.010 |
Why?
|
Methotrexate | 1 | 2010 | 1721 | 0.010 |
Why?
|
Drug Evaluation | 1 | 2004 | 642 | 0.010 |
Why?
|
Cytokines | 1 | 2018 | 7453 | 0.010 |
Why?
|
Amyloidosis | 1 | 2010 | 878 | 0.010 |
Why?
|
RNA, Viral | 1 | 2010 | 2872 | 0.010 |
Why?
|
Antiretroviral Therapy, Highly Active | 1 | 2010 | 1903 | 0.010 |
Why?
|
Cooperative Behavior | 1 | 2009 | 1514 | 0.010 |
Why?
|
Cholesterol | 1 | 2010 | 2914 | 0.010 |
Why?
|
Cell Adhesion Molecules | 1 | 2007 | 1613 | 0.010 |
Why?
|
Interleukin-1 | 1 | 2004 | 1252 | 0.010 |
Why?
|
Immunoglobulins, Intravenous | 1 | 2005 | 667 | 0.010 |
Why?
|
Radiography | 1 | 2011 | 6983 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2018 | 15948 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2009 | 6082 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 2010 | 6316 | 0.010 |
Why?
|
Safety | 1 | 2004 | 1159 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 3 | 2011 | 36743 | 0.010 |
Why?
|
Cost-Benefit Analysis | 1 | 2010 | 5536 | 0.010 |
Why?
|
Interleukin-2 | 1 | 2004 | 1895 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2015 | 20227 | 0.010 |
Why?
|
Evidence-Based Medicine | 1 | 2009 | 3706 | 0.010 |
Why?
|
Adrenal Cortex Hormones | 1 | 2005 | 1886 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2018 | 18065 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2006 | 8542 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2015 | 26379 | 0.010 |
Why?
|
Anti-Bacterial Agents | 1 | 2010 | 7477 | 0.010 |
Why?
|
Prognosis | 1 | 2007 | 30010 | 0.000 |
Why?
|
Risk Assessment | 1 | 2007 | 24315 | 0.000 |
Why?
|
Inflammation | 1 | 2004 | 10873 | 0.000 |
Why?
|